Humana (HUM) Tops Q2 EPS by 41c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Humana (HUM) PT Raised to $230 at Cantor Fitzgerald Following 2Q Release
August 2, 2017 1:17 PM EDTCantor Fitzgerald raised its price target on Humana (NYSE: HUM) to $230.00 (from $200.00) while maintaining a Neutral rating following the company's 2Q earnings report. Non-GAAP EPS was $3.49 vs. recast 2Q16 nonGAAP EPS of $3.29. Medicare revenue grew 3.3% y/y compared to 1.2% in 1Q17.
The company... More
